Reported 458,742 shares, up 193,742 (73.1%) from the prior quarter.
Reported value 69.2%; share count 73.1% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-12-31 | 0 |
| 2026-03-31 | 4107500 |
| 2026-06-30 | 6428900 |
| 2026-09-30 | 10876773 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2026 | Added | 458,742 | +193,742 (73.1%) | 3.76% | $10,876,773 | 2026-11-16 | |
| Q2 2026 | Unchanged | 265,000 | 0 (0.0%) | 1.77% | $6,428,900 | 2026-08-14 | |
| Q1 2026 | New | 265,000 | +265,000 (0.0%) | 1.52% | $4,107,500 | 2026-05-15 | |
| Q4 2021 | Reduced | 0 | -451,522 (-100.0%) | 0 | $0 | 2022-02-11 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
255 managers reported NURIX THERAPEUTICS INC for Q3 2026.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| BlackRock Inc | Added | 8,801,242 | +30,893 | < 0.01% | $208,677,448 | 9 qtrs |
| Redmile Group LLC | Added | 7,901,085 | +3,827,298 | 13.71% | $187,334,725 | 25 qtrs |
| Vestal Point Capital LP | Reduced | 7,025,000 | -1,025,000 | 4.3% | $166,562,750 | 10 qtrs |
| Deep Track Capital LP | Reduced | 6,000,000 | -1,736,455 | 2.32% | $142,260,000 | 18 qtrs |
| PERCEPTIVE ADVISORS LLC | Added | 5,371,629 | +1,051,207 | 2.22% | $127,361,324 | 8 qtrs |
| MORGAN STANLEY | Added | 5,246,511 | +484,027 | < 0.01% | $124,394,806 | 25 qtrs |
| Rubric Capital Management LP | Reduced | 4,966,827 | -2,260,951 | 1.11% | $117,763,468 | 4 qtrs |
| FMR LLC | Reduced | 4,679,815 | -805,400 | < 0.01% | $110,958,424 | 25 qtrs |
| BAKER BROS ADVISORS LP | Unchanged | 4,658,556 | 0 | 0.52% | $110,454,363 | 25 qtrs |
| PRICE T ROWE ASSOCIATES INC MD | Reduced | 4,570,774 | -865,813 | 0.01% | $108,374,000 | 25 qtrs |
Filing details and methodology As reported
- Report period
- September 30, 2026
- Filed
- November 16, 2026
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 458,742
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.